DEUTSCHE BANK AG\ - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 61 filers reported holding MARKER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$45,000
+45.2%
19,972
-8.5%
0.00%
Q4 2020$31,000
+6.9%
21,820
+14.4%
0.00%
Q3 2020$29,000
-14.7%
19,070
+16.0%
0.00%
Q2 2020$34,000
-38.2%
16,446
-43.1%
0.00%
Q1 2020$55,000
-49.5%
28,908
-24.8%
0.00%
Q4 2019$109,000
+179.5%
38,439
+381.2%
0.00%
Q3 2019$39,000
-77.1%
7,988
-63.1%
0.00%
Q2 2019$170,00021,6680.00%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 3,142,857$2,986,0001.05%
ACT CAPITAL MANAGEMENT, LLC 354,400$337,0000.24%
NEA Management Company, LLC 10,714,285$10,179,0000.21%
Long Focus Capital Management, LLC 1,233,257$1,172,0000.16%
Mandatum Life Insurance Co Ltd 99,000$94,0000.02%
MATRIX ASSET ADVISORS INC/NY 150,000$143,0000.02%
AR ASSET MANAGEMENT INC 71,500$68,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 590,118$561,0000.01%
WealthTrust Axiom LLC 22,700$21,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 324,216$308,0000.01%
View complete list of MARKER THERAPEUTICS INC shareholders